Dexcom (DXCM) Long-Term Debt Issuances (2017 - 2018)
Dexcom (DXCM) posted quarterly Long-Term Debt Issuances of $836.6 million for Q4 2018, up 1215.47% quarter-over-quarter from -$75.0 million in Q3 2017.
Dexcom (DXCM) Long-Term Debt Issuances (2017 - 2018) Analysis & Trends
Dexcom (DXCM) has reported Long-Term Debt Issuances for 2 consecutive years, with $836.6 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Long-Term Debt Issuances changed N/A year-over-year to $836.6 million; the TTM figure through Sep 2020 stood at $836.6 million (changed 0.0% YoY), while the FY2023 annual figure was $1.2 billion, changed N/A from the prior year.
- Long-Term Debt Issuances rose to $836.6 million in Q4 2018 per DXCM's latest filing, from -$75.0 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $836.6 million in Q4 2018 and bottomed at -$75.0 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -33.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 109.26 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 836.60 Mn |
| Dec 31, 2018 | 836.60 Mn |
| Sep 30, 2017 | 389.00 Mn |
| Sep 30, 2017 | 389.00 Mn |
| Jun 30, 2017 | 389.00 Mn |
| Jun 30, 2017 | 389.00 Mn |
| Mar 31, 2017 | 75.00 Mn |
| Mar 31, 2017 | 75.00 Mn |